OrthoSpin has developed a smart, robotic external fixation system used for bone lengthening, setting complex fractures and correcting deformities. Its Generation 1 system is FDA-cleared and has completed initial clinical cases in the U.S. and Israel. The system automates pre-programmed adjustments without patient involvement and includes integrated software for physicians to chart progress and adjust treatments when required. The company is led by CEO Oren Cohen and is advancing a Generation 2 system. OrthoSpin raised funds to accelerate Gen 2 product development and to move the Gen 2 system into clinical use later in the year. The company is based in Misgav, Israel. OrthoSpin builds a robotic external fixation system that makes pre-programmed adjustments automatically and continuously, removing the need for patient involvement. The system includes integrated software that enables physicians to chart patient progress and immediately adjust treatment programs when required. The company plans to use newly raised funds to accelerate its development process and broaden its clinical trials. OrthoSpin is led by CEO Oren Cohen and was founded in December 2014. The company is based in Misgav, Israel and is a portfolio company of The Trendlines Group Ltd.

Total raised

$8M

Funding rounds

2

Latest round

Series B

Latest activity

Mar 2020